首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Development of a Geant4‐based independent patient dose validation system with an elaborate multileaf collimator simulation model
【2h】

Development of a Geant4‐based independent patient dose validation system with an elaborate multileaf collimator simulation model

机译:基于Geant4的独立患者剂量验证系统的开发该系统具有完善的多叶准直器仿真模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the improvements in the dose calculation models of the commercial treatment planning systems (TPS), their ability to accurately predict patient dose is still limited. One of the limitations is caused by the simplified model of the multileaf collimator (MLC). The aim of this study was to develop a Monte Carlo (MC) method‐based independent patient dose validation system with an elaborate MLC model for more accurate dose evaluation. Varian Clinac 2300 IX was simulated using Geant4 toolkits, after which MC commissioning with measurements was performed to validate the simulation model. A DICOM‐RT interface was developed to obtain the beam delivery conditions including the hundreds of MLC motions. Finally, the TPS dose distributions were compared with the MC dose distributions for water phantom cases and a patient case. Our results show that the TPS overestimated the absolute abutting leakage dose in the closed MLC field, with about 20% more of the maximum dose than that of the MC calculation. For water phantom cases, the dose distributions inside the target region were almost identical with the dose difference of less than 2%, while the dose near the edge of the target shows difference about 10% between Geant4 and TPS due to geometrical differences in MLC model. For the patient analysis, the Geant4 and style="fixed-case">TPS doses of all organs were matched well within 1.4% of the prescribed dose. However, for organs located in areas with high ratio of leaf pairs with distances less than 10 mm leaf pair ( style="fixed-case">LP (<10mm)), the maximum dose of style="fixed-case">TPS was overestimated by about 3% of the prescribed dose. These dose comparison results demonstrate that our system for calculating the patient dose is quite accurate. Furthermore, if the style="fixed-case">MLC sequences in treatment plan have a large ratio of style="fixed-case">LP (short), more than 3% dose difference in normal tissue could be seen.
机译:尽管商业治疗计划系统(TPS)的剂​​量计算模型有所改进,但其准确预测患者剂量的能力仍然有限。限制之一是由多叶准直器(MLC)的简化模型引起的。这项研究的目的是开发一种基于蒙特卡洛(MC)方法的独立患者剂量验证系统,该系统具有精心设计的MLC模型,以进行更准确的剂量评估。使用Geant4工具箱对Varian Clinac 2300 IX进行了仿真,然后进行了带有测量值的MC调试,以验证仿真模型。开发了DICOM‐RT接口以获取包括数百种MLC运动的光束传输条件。最后,将TPS剂量分布与水体模病例和患者病例的MC剂量分布进行比较。我们的结果表明,TPS在封闭的MLC场中高估了绝对邻接泄漏剂量,最大剂量比MC计算多了大约20%。对于水幻影的情况,目标区域内的剂量分布几乎相同,剂量差异小于2%,而目标边缘附近的剂量由于MLC模型中的几何差异而在Geant4和TPS之间显示出约10%的差异。 。对于患者分析,所有器官的Geant4剂量和 style =“ fixed-case”> TPS 剂量在规定剂量的1.4%之内完全匹配。但是,对于位于叶对比例高且距离小于10毫米叶对( style =“ fixed-case”> LP (<10mm))的区域中的器官, style =“ fixed-case”> TPS 被高估了处方剂量的3%。这些剂量比较结果表明,我们用于计算患者剂量的系统非常准确。此外,如果治疗计划中的 style =“ fixed-case”> MLC 序列中 style =“ fixed-case”> LP 的比例较大(短),则大于3可以看到在正常组织中的%剂量差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号